15.03.2016 11:06:33

Earnings Reported After The Bell Mar.14

(RTTNews) - Here is a quick summary of the earnings reported after the bell on Mar.14.

Oncothyreon Inc. (ONTY)

Q4 net loss was $9.1 million, or $0.10 per share, compared with a net loss of $27.6 million, or $0.30 per share a year ago.

***

Connecticut Water Service, Inc. (CTWS)

Q4 net income was $2.2 million, or $0.20 per share compared to $2.4 million, or $0.21 per share a year ago.

***

Chiasma, Inc. (CHMA)

Q4 net loss attributable to common stockholders was $14.5 million, or $0.61 per share, compared to $8.9 million, or $199.86 per share a year ago.

***

Inogen, Inc. (INGN)

Q4 net income increased to $3.9 million or $0.19 per share from $1.5 million or $0.07 per share in the fourth quarter of last year.

Total revenue rose 38.9% to $40.4 million, from $29.1 million a year ago.

FY Outlook

Revenue is expected to range from $187 million to $191 million.

Adjusted net income is expected to be in the range of $12 million to $14 million.

Net income is expected to be in the range of $12 million to $14 million.

***

Akebia Therapeutics, Inc. (AKBA)

Q4 net loss was $19.9 million, or $0.66 per share vs. net loss of $10.4 million or $0.52 per share a year ago.

***

Bellicum Pharmaceuticals, Inc. (BLCM)

Q4 net loss was $16.8 million or $0.63 per share compared to net loss of $74.3 million or $18.78 per share a year ago.

Grant revenues were $34000 vs. $14000 a year ago.

***

Numerex Corp. (NMRX)

Q4 loss from continuing operations was $2.4 million or $0.13 per share compared to net income of $601 thousand or $0.03 per share a year ago.

Net revenues were $18.8 million compared to $24.9 million a year ago.

***

Amphastar Pharmaceuticals, Inc. (AMPH)

Q4 GAAP net income was $7.5 million, or $0.16 per share vs. net loss of $2.52 million or $0.06 per share a year ago.

Adjusted net income was $9.1 million, or $0.19 per share vs. loss of $1.5 million or $0.03 per share a year ago.

Net revenues were $76.9 million vs. $55.88 million a year ago.

***

Aratana Therapeutics, Inc. (PETX)

Q4 net loss was $12.9 million or $0.37 per share compared to net loss of $10.3 million, or $0.30 per share a year ago.

Revenue was $63000 vs. $248000 a year ago.

***

ChemoCentryx, Inc., (CCXI)

Q4 net loss was $11.6 million or $0.26 per share compared to net loss of $12.2 million or $0.28 per share a year ago.

***

BioAmber Inc. (BIOA)

Q4 net loss was $7.6 million vs. net loss of $3.95 million a year ago.

Adjusted loss was $10.39 million or $0.40 per share vs. loss of $10.38 million or $0.48 per share a year ago.

***

Black Diamond, Inc. (BDE)

Q4 net loss from continuing operations was $31.7 million or $0.99 per share, compared to loss of $3.1 million or $0.09 per share in the year-ago quarter.

Adjusted net income from continuing operations increased to $0.6 million or $0.02 per share compared to an adjusted net loss from continuing operations of $0.5 million or $0.02 per share a year ago.

Sales in the fourth quarter decreased 4% to $44.1 million compared to $46.0 million in the same year-ago quarter.

***

Solazyme, Inc. (SZYM)

Q4 GAAP net loss was $34.7 million or $0.43 per share compared to net loss of $44.9 million or $0.57 per share in the prior year period.

Non-GAAP net loss was $26.1 million or $0.32 per share compared with net loss of $35.5 million or $0.45 per share in the prior year quarter.

Total revenue for the fourth quarter was $10.4 million compared with $14.5 million a year ago.

***

Jamba, Inc. (JMBA)

Q4 GAAP net loss attributable to Jamba, Inc. was $8.3 million or $0.55 per share compared to $8.0 million, or $0.47 per share for the prior year.

Non-GAAP net loss attributable to Jamba, Inc. was $4.2 million or $0.28 per share compared to $4.7 million, or $0.27 per share for the prior year.

Revenue was $19.55 million vs. $43.93 million a year ago.

***

Connecture, Inc. (CNXR)

Q4 net income was $4.32 million or $0.19 per share compared to $4.78 million or $0.30 per share a year ago.

Total revenue was $29.1 million, increasing 4.7% compared to $27.8 million a year ago.

Analysts expected the company to report net income of $0.26 per share on revenues of $30.32 million for the period.

FY Outlook

Total revenue is expected to be in the range of $100.0 million to $110.0 million.

Analysts expect the company to report revenues of $112.64 million for the period.

***

PFSweb, Inc. (PFSW)

Q4 net loss in the fourth quarter was $0.6 million or $0.03 per share, compared to net income of $2.1 million or $0.12 per share a year ago.

Non-GAAP net income in the fourth quarter was $3.1 million or $0.16 per share, compared to $3.9 million or $0.21 per share a year ago.

Total revenues in the fourth quarter increased 14% to $90.1 million compared to $78.7 million a year ago.

***

Ducommun Incorporated (DCO)

Q4 net loss was $63.6 million, or $5.74 per share compared to net income of $5.2 million, or $0.46 per share a year ago.

Revenue was $156.6 million compared to $187.6 million a year ago.

***

Fuel Systems Solutions, Inc. (FSYS)

Q4 net loss was $6.9 million, or $0.38 per share, compared to net loss of $4.0 million, or $0.20 per share a year ago.

Total revenue for the fourth quarter was $67.3 million compared to $85.4 million a year ago.

***

Rosetta Stone Inc. (RST)

Q4 net loss improved 47% to $11.4 million or $0.52 per share, compared to net loss of $21.5 million or $1.01 per share in the year-ago period.

Total revenue was down 27% year-over-year to $58.0 million.

***

iKang Healthcare Group, Inc. (KANG)

Q3 net income was $20.3 million, an increase of 13.4% year-over-year.

Non-GAAP net income was $20.7 million, an increase of 11.9% year-over-year.

EPADS was $0.29 as compared to $0.25 a year ago.

Non-GAAP income per ADS was $0.30 as compared to $0.26 a year ago.

Net revenues were $133.0 million vs. $108.6 million in the same period of the last fiscal year.

Analysts expected the company to report net income of $0.33 per share on revenues of $141.97 million for the period.

***

China New Borun Corporation (BORN)

Q4 net income increased 306.6% to RMB53.2million or $8.2 million from RMB13.1 million a year ago.

EPADS were RMB2.07 or $0.32.

Revenue increased 14.6% to RMB699.1 million or $107.7 million from RMB610.0 million a year ago.

Q1 Outlook

Revenue for the first quarter to be in the range of RMB510 million or $78.5 million to RMB540 million or $83.2 million.

***

Aoxin Tianli Group, Inc. (ABAC)

Q4 net income attributable to common shareholders was $2.94 million, or $0.09 per share vs. $1.95 million, $0.07 per share, for the same period of last year.

Revenues decreased by 21.9%, to $8.75 million from $11.20 million for the same period of last year.

***

CUI Global, Inc. (CUI)

Q4 net loss was $1.3 million or $0.06 per share compared with net loss of $1.9 million or $0.09 per share in the prior year period.

Revenues were $21.9 million vs. $18.6 million a year ago.

***

ITT Educational Services, Inc. ( ESI)

Q4 net income was $10.4 million or $0.44 per share vs. $14.6 million or $0.62 per share a year ago.

Revenue was $202.4 million vs. 243.2 million a year ago.

***

Arotech Corporation (ARTX)

Q4 net income was $399,000, or $0.02 per share, compared to $312,000, or $0.01 per share, for the corresponding period last year.

Adjusted EPS was $0.06 versus $0.02 for the same time last year

Total revenues was $27.4 million versus $28.6 million for the same time last year

FY Outlook

Revenue to be in the range of $100 million to $112 million, with adjusted earnings per share in the range of $0.18 to $0.23.

***

MannKind Corporation (MNKD)

Q4 net loss was $277.02 million or $0.66 per share vs. net loss of $36.44 million or $0.09 per share a year ago.

***

Xerium Technologies Inc. (XRM)

Q4 net loss was $6.33 million or $0.40 per share vs. net income of $11.16 million or $0.68 per share a year ago.

Net sales were $115.35 million vs. $130.97 million a year ago.

***

TeleTech Holdings, Inc. (TTEC)

Q4 net Income Attributable to TeleTech Stockholders was $17 .00 million or $0.35 per share vs. $21.97 million or $0.44 per share a year ago.

Non-GAAP EPS was $0.47 per share compared to $0.46 per share in the prior year.

Analysts expect the company to report net income of $0.52 per share for the period.

Revenue increased 1.1 percent to $341.8 million compared to $338.2 million in the prior year period.

Non-GAAP revenue increased 5.6 percent to $357.0 million over the prior year.

FY Outlook

GAAP revenue is estimated to be between $1.335 billion and $1.345 billion.

Analysts expect the company to report revenues of $1.36 billion for the period.

***

Cellectis (CLLS)

Q4 net income attributable to shareholders of Cellectis was €8.2 million or €0.23 per share.

Adjusted net income attributable to shareholders of Cellectis was €20.9 million or €0.59 per share.

Revenue was €29.18 million.

***

Amaya Inc. (AYA)

Q4 net loss from continuing operations was $15.76 million or $0.07 per share vs. net income of $35.59 million or $0.17 per share a year ago.

Adjusted net earnings were $111.25 million or $0.53 per share vs. 87.87 million or $0.17 per share a year ago.

Revenue was $389.51 million vs. $339.41 million a year ago.

***

Vivint Solar (VSLR)

Q4 net loss available to common stockholders was $13.19 million or $0.12 per share vs. net loss of $6.14 million or $0.06 per share a year ago.

Revenue was $16.03 million vs. $6.86 million a year ago.

***

Real Industry, Inc. (:RELY)

Q4 net loss was $4.6 million or $0.16 per share vs. net income of $5.1 million or $0.39 per share a year ago.

Revenue was $300.5 million vs. $2.0 million a year ago.

***

Fortuna Silver Mines Inc. (FSM)

Q4 net loss was $17.3 million vs. net income of $0.1 million a year ago.

Adjusted net loss was $0.1 million, compared to income of $0.2 million a year ago.

Sales were $37.0 million, compared to $37.8 million a year ago.

***

Nachrichten zu TeleTech Holdings Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu TeleTech Holdings Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!